| Bioactivity | GAT211 is a cannabinoid 1 receptor (CB1R) positive allosteric modulator (PAM). GAT211 can be used for neuropathic and/or inflammatory pain research[1]. | ||||||||||||
| Name | GAT211 | ||||||||||||
| CAS | 102704-40-5 | ||||||||||||
| Formula | C22H18N2O2 | ||||||||||||
| Molar Mass | 342.39 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Richard A Slivicki, et al. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence. Biol Psychiatry. 2018 Nov 15;84(10):722-733. |